Form D · Other Health Care
PAVmed Inc.
New York, NY · CIK 0001624326
Offering snapshot reported Feb 17, 2026 · SEC filing
- Reported sold
- $30M Offering amount: $60M
- Investors reported
- 14 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Feb 3, 2026 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Feb 17, 2026 | Initial | $30,000,000 | No comparison | 14 | SEC filing |
| Feb 7, 2025 | Initial | $2,653,000 | No comparison | 1 | SEC filing |
| Aug 11, 2020 | Initial | $7,750,000 | No comparison | 1 | SEC filing |
| May 1, 2020 | Initial | $4,111,111 | No comparison | 1 | SEC filing |
| Nov 7, 2019 | Initial | $14,000,000 | No comparison | 2 | SEC filing |
| Jan 9, 2019 | Initial | $7,750,000 | No comparison | 1 | SEC filing |
| Aug 29, 2017 | Initial | $500,000 | No comparison | 6 | SEC filing |
| Feb 7, 2017 | Initial | $1,508,004 | No comparison | 13 | SEC filing |
| Nov 24, 2014 | Amendment | $845,000 | $0vs Nov 19, 2014 | 12 | SEC filing |
| Nov 19, 2014 | Initial | $845,000 | No comparison | 12 | SEC filing |
Offering details
- Securities
- Equity, Option to acquire, Security to be acquired
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-573645
The company sold 30,000 shares of Series D Convertible Preferred Stock at $1,000 per share, with the investors receiving warrants to purchase an additional 30,000 shares of Series D Convertible Preferred Stock at $1,000 per share.
Source: Form D, filed Feb 17, 2026. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Sundeep Agrawal | Director |
| Lishan Aklog | Director, Executive |
| Lishan Aklog, M.D. | Director, Executive |
| David S. Battleman, M.D. | Director |
| Timothy E. Baxter | Director |
| James L Cox | Director |
| James L. Cox, M.D. | Director |
| Brian Justo De Guzman | Director, Executive |
| Brian J. De Guzman, M.D. | Executive |
| Richard Fitzgerald | Executive |
| Michael J. Glennon | Director |
| Michael A. Gordon | Executive |
| Ira Scott Greenspan | Director |
| Ira Scott Grenspan | Director |
| Joshua R. Lamstein | Director |
| Dennis M. Mc Grath | Executive |
| Shaun M. O'neil | Executive |
| Richard J. Salute | Director, Executive |
| Ronald M. Sparks | Director |
| David Scott Weild, Iv | Director |
| Debra J. White | Director |
| Richard Yazbeck | Executive |
Issuer details
Industry: Other Health Care (See others in industry)
Address:
360 Madison Avenue 25 Th Floor
New York, NY, 10017
New York, NY, 10017